Fed Governor Adriana Kugler to resign
Arteris , Inc. (NASDAQ:AIP) Chief Operating Officer Moll Laurent R has recently sold shares of the semiconductor company, according to a recent SEC filing. On April 2, Laurent R sold a total of 4,703 shares at approximately $7.12 per share, amounting to a total of $33,478. The transactions were made to satisfy tax liabilities arising from the release of restricted stock units. The stock, which has fallen over 41% year-to-date and currently trades near its 52-week low, shows signs of being undervalued according to InvestingPro analysis. Despite recent price weakness, the company maintains impressive gross profit margins of nearly 90%.
Additionally, on April 4, Laurent R sold another 1,260 shares at $6.15 per share, under a pre-established 10b5-1 trading plan, totaling $7,749. Following these transactions, Laurent R now holds 481,573 shares of Arteris. These sales reflect strategic financial planning and adherence to regulatory compliance by the COO. For deeper insights into Arteris’s valuation and 10+ additional exclusive ProTips, check out the comprehensive research report available on InvestingPro.
In other recent news, Arteris, Inc. reported revenue that aligned with expectations for the quarter, as noted by Northland analysts, who raised the company’s stock price target to $16 while maintaining an Outperform rating. The company’s bookings reached approximately $33.6 million, with a book-to-bill ratio of 2.2:1, and the FlexNoC 5 product accounted for a significant portion of interconnect licenses. Northland’s revised price target also reflects the anticipated impact of Arteris’ new product, FlexGen, which is expected to provide a 30% average selling price uplift. Jefferies analysts also adjusted their price target for Arteris to $11, maintaining a Hold rating, citing recent progress in the microcontroller unit market and the potential of the FlexGen solution. Despite these positive developments, Jefferies remains cautious due to lower-than-expected 2025 guidance. Additionally, Arteris announced the resignation of board member Isabelle F. Geday, effective March 27, 2025, due to personal reasons. The company has not announced plans for replacing Geday on the board. These developments highlight Arteris’ strategic moves and product introductions, which suggest potential growth opportunities and a shift toward improved financial performance in the coming years.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.